VRAX 주가 차트
VRAX 재무
Virax Biolabs Group Ltd
$0.31
3.23%
$0.01
종가: May 20, 16:00:00 GMT-4
$0.29
-7.55%
$-0.02
애프터마켓: May 20, 18:08:06 GMT-4
뒤로
Virax Biolabs Group Ltd (VRAX) 재무
주요 통계
이전 종가
$0.309
시가
$0.246
일일 범위
$0.2451 - $0.368
52주 범위
$0.1 - $1.2
거래량
22.2M
평균 거래량
8.9M
배당수익률
--
EPS(TTM)
-1.25
시가총액
$5.8M
VRAX란 무엇인가요?
Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The firm is engaged in developing ViraxImmune with the intention of providing an immunology profiling platform that assesses each individual’s immune risk profile against global viral diseases as well as helping with the early diagnosis of post-viral syndromes associated with T cell exhaustion and chronic inflammation. Its product portfolio includes ViraxClear and ViraxVet. ViraxClear offers a range of accurate diagnostic testing kits and machines. ViraxVet offers various rapid and molecular tests for small animal veterinary diagnostics. The firm is initially focused on diseases associated with post-viral syndromes, including SARS-CoV-2, Human Papillomavirus (HPV), Malaria, Hepatitis B, and Herpes (HSV-1).
